CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 17 enrolled
Drug / intervention
Promogran Prisma +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04050124
NCT04050124N/ACompleted
CompareCT.gov

Impact of Promogran Prisma™ on Pain of Split-thickness Skin Graft Donor Sites Compared to Standard of Care Alone

NYU Langone Health·interventional·Posted Aug 8, 2019·Updated Apr 16, 2024

In Brief

A clinical study evaluating Promogran Prisma and Standard of care (SOC) dressings for Skin Graft Disorder and Donor Site Complication. Completed, enrolled 17 participants across 1 site.

Detailed Summary

The purpose of this study is to assess the feasibility of evaluating the use of a composite collagen, silver-oxidized regenerated cellulose matrix compared to the standard of care dressing on donor site pain for patients undergoing split-thickness skin grafting in preparation for a larger study.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSkin Graft Disorder, Donor Site Complication
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedAug 8, 2019
Enrollment StartNov 7, 2019
Primary CompletionNov 29, 2021
TodayJul 2, 2026
Enrollment to primary: 2.1 yearsPosted 6.9 years ago

Interventions

Promogran Prismadevice

Promogran+SOC; composite collagen, silver-oxidized regenerated cellulose matrix

Standard of care (SOC) dressingsdevice

standard of care dressing on donor site pain for patients undergoing split-thickness skin grafting in preparation for a larger study.